Engineering the future of human life.

We study disease as a system, from a single cell to an entire population, and turn what we learn into medicine.

What we do

Disease is an intrinsically complex systems problem. Our research network is purpose-built to understand it.

We combine virology, genetics and advanced chemistry to study life at the scale of a single cell.

Every discovery moves through one protocol, from the laboratory to the people who need it.

Research platform

Combiningvirology,geneticsandchemistryintooneresearchplatform.

Our laboratories in Raccoon City, Paris and Tokyo work from a shared library of compounds, cell lines and genomic data. Each programme is reviewed against the same protocol before it advances, so a finding in one city can be tested in another within days.

Explore the platform

Virology

Mapping how viral vectors enter, adapt to and change a host cell.

Genetics

Sequencing and editing the regulatory networks that control cell growth.

Chemistry

Designing compounds that act on those networks with clinical precision.

The biology of life itself — Raccoon City — Paris — Tokyo — Rockfort —

Our company

Glass vials of deep crimson solution held in a brushed steel rack.

Founded in 1968 to advance human health through science, Umbrella Corporation operates on four continents under a single research protocol.

Umbrella was established by Lord Oswell E. Spencer with a mandate to study life at its most fundamental level. Its first laboratory opened outside Raccoon City, where the company maintains its global headquarters and principal research facility.

Today, Umbrella employs researchers, clinicians and engineers across Raccoon City, Paris, Tokyo and Rockfort. Our medicines and consumer products reach households in more than forty countries, and every one of them begins in the same laboratories.

About Umbrella

Divisions